Search Results - "Mateva, Lyudmila"

Refine Results
  1. 1
  2. 2

    Actinomycosis: a frequently forgotten disease by Boyanova, Lyudmila, Kolarov, Rossen, Mateva, Lyudmila, Markovska, Rumyana, Mitov, Ivan

    Published in Future microbiology (01-04-2015)
    “…Actinomycosis is a rare subacute or chronic, endogenous infection mainly by species, showing low virulence through fimbriae and biofilms. Cervicofacial,…”
    Get full text
    Journal Article
  3. 3

    Effect of Moderate Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor by Groenendaal-van de Meent, Dorien, Adel, Martin den, Noukens, Jan, Rijnders, Sanne, Krebs-Brown, Axel, Mateva, Lyudmila, Alexiev, Assen, Schaddelee, Marloes

    Published in Clinical drug investigation (01-09-2016)
    “…Background and Objective Roxadustat is a hypoxia-inducible factor prolyl hydroxylase inhibitor in phase III development for the treatment of anaemia associated…”
    Get full text
    Journal Article
  4. 4

    Association of Serum Lipids with Hepatic Steatosis, Stage of Liver Fibrosis and Viral Load in Chronic Hepatitis C by Valkov, Ivan, Ivanova, Radina, Alexiev, Assen, Antonov, Krasimir, Mateva, Lyudmila

    “…Hepatitis C Virus (HCV) relies on host lipids for its life cycle contributing to lipid abnormalities and hepatic steatosis. Disease progression is influenced…”
    Get full text
    Journal Article
  5. 5

    Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma by Krastev, Zahariy, Jelev, Deian, Antonov, Krasimir, Petkova, Tanya, Atanasova, Evelina, Zheleva, Nadezhda, Tomov, Bojidar, Boyanova, Yana, Mateva, Lyudmila

    Published in World journal of gastroenterology : WJG (28-02-2016)
    “…We observed a sustained viral response(SVR) of ombitasvir/paritaprevir/ritonavir, dasabuvir and ribavirin therapy, for 12 wk, in two cases with compensated…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    THE CYTOKINE IP-10 IN CHRONIC HBV AND HCV INFECTION by Nikolova, Nina S., Antonov, Krasimir, Jelev, Deian, Mateva, Lyudmila, Krastev, Zahariy

    Published in Journal of IMAB (04-08-2013)
    “…Introduction: IP-10 it has been studied as a predictor of treatment response in chronic HCV infected patients. The data for the HBV infection are not…”
    Get full text
    Journal Article
  10. 10

    Simultaneous Determination of Free Polyamines, Catecholamines and Metanephrines in Plasma and Urine by Mateva, Lyudmila V., Sv. Petrov, Stefan, St. Lozanov, Valentin, Elenkova, Atanaska P., Zacharieva, Sabina, Iv. Mitev, Vanio

    “…We describe a new, rapid, and sensitive HPLC method with fluorescent detection for simultaneous analysis of plasma and urine free catecholamines,…”
    Get full text
    Journal Article
  11. 11

    A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe by Lazarus, Jeffrey V., Ekstedt, Mattias, Marchesini, Giulio, Mullen, Jillian, Novak, Katja, Pericàs, Juan M., Roel, Elena, Romero-Gómez, Manuel, Ratziu, Vlad, Tacke, Frank, Cortez-Pinto, Helena, Anstee, Quentin M.

    Published in Journal of hepatology (01-01-2020)
    “…[Display omitted] •A comprehensive public health response to NAFLD is lacking in the 29 countries.•Major gaps include strategies, clinical guidelines,…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Monoallelic expression of the TTR gene as a contributor to the age at onset and penetrance of TTR-related amyloidosis by Yordanova, Iglika, Pavlova, Zornitza, Kirov, Andrey, Todorov, Tihomir, Alexiev, Assen, Sarafov, Stayko, Mateva, Lyudmila, Chamova, Teodora, Gospodinova, Mariana, Mitev, Vanyo, Tournev, Ivailo, Todorova, Albena

    Published in Gene (15-07-2019)
    “…TTR-related amyloidosis (ATTR) is manifested in two allelic forms: familial amyloid polyneuropathy (TTR-FAP) and cardiomyopathy (TTR-FAC), both caused by…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    The decrease of HBsAg during nucleos(t)ide analogues (NUC) therapy in Bulgarian patients by Nikolova, Nina, Jelev, Deian, Antonov, Krasimir, Mateva, Lyudmila, Krastev, Zahariy

    Published in Biotechnology, biotechnological equipment (04-07-2015)
    “…Serum surface antigen of the hepatitis B virus (HBsAg) level has been recently introduced and studied during the last years as a simple and non-invasive serum…”
    Get full text
    Journal Article
  19. 19

    Effects of Hepatic Dysfunction on the Single-Dose Pharmacokinetics of Fesoterodine by de Mey, Christian, Mateva, Lyudmila, Krastev, Zahariy, Sachse, Richard, Wood, Nolan, Malhotra, Bimal

    Published in Journal of clinical pharmacology (01-03-2011)
    “…Fesoterodine, a new antimuscarinic for the treatment of overactive bladder, is rapidly and extensively hydrolyzed by nonspecific esterases to its principal…”
    Get full text
    Journal Article
  20. 20